Immune Repertoire Sequencing Market
- 2026 年市場規模
- USD 181.1 Mn
- 2033 年預估規模
- USD 263.0 Mn
- 年複合成長率 CAGR
- 5.6%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Immune Repertoire Sequencing Market, By Product Type (Assay Kits (T-Cell Receptor Kits, and B-Cell Receptor Kits) and Instruments), By Application (Cancer Immunotherapy, Biomarker Discovery, Autoimmune Diseases, Vaccine Development and Efficacy, Transplant Rejection and Tolerance, Infectious Diseases, and Other Applications), By End User (Diagnostic Labs, Biotechnology and Pharmaceutical Companies, Academic and Research Institutes, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
報告摘要
Immune repertoire refers to sub-type protein that an organism’s immune system creates. Immune systems in vertebrates have six key types of proteins- two immunoglobulin and four T cell receptors. Immune repertoire sequencing enables researchers and scientists to examine and understand adaptive immune-mediated diseases. Immune repertoire sequencing is also widely applicable in biomarker discovery, infectious disease research, asthma and allergy research, and cancer immunotherapy.
Market Dynamics
Increasing prevalence of cancer worldwide is expected to boost immune repertoire sequencing market growth. According to National Cancer Institute, 2016, an estimated 16.8 million new cases of cancer were diagnosed in the U.S., with around 595,690 deaths from the disease. Moreover, the number of people suffering from cancer is expected to reach to 19 million by 2024. According to the Cancer Atlas, 2012, about 1.1 million new cancer cases and 600,000 cancer deaths are reported annually in Latin America and the Caribbean, where lung cancer is the leading cause of cancer death for both sexes.
However, factors such as high cost associated with certain sequencing platforms and data analytic services coupled with product recalls are expected to hinder growth of the immune repertoire sequencing market during the forecast period. For instance, in 2015, Illumina Inc. recalled its Illumina MiSeqDx Universal Kit 1.0, due to software limitation when using the product on MiSeqDx instrument. The software could not report insertions or deletions at specific genomic locations with respect to the primer.
Key features of the study
• This report provides in-depth analysis of the immune repertoire sequencing market, market size (USD Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2026 – 2033, considering 2025 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
• It profiles key players in the global immune repertoire sequencing market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study include Thermo Fisher Scientific, Inc., Illumina Inc., ArcherDX, Inc., Roche Holding AG, Pacific Biosciences, CD Genomics, Atreca, Inc., Adaptive Biotechnologies, Oxford Nanopore Technologies, Ltd., Qiagen N.V., Agilent Technologies, Inc., and Takara Bio, Inc.
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
• The global immune repertoire sequencing market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for immune repertoire sequencing market, research and consulting firms, new entrants, and financial analysts
Market Segmentation
• By Product Type
o Assay Kits
T-Cell Receptor (TCR) Kits
B-Cell Receptor (BCR) Kits
o Instruments
• By Application
o Cancer Immunotherapy
o Biomarker Discovery
o Autoimmune Diseases
o Vaccine Development and Efficacy
o Transplant Rejection and Tolerance
o Infectious Diseases
o Other Applications
• By End User
o Diagnostic Labs
o Biotechnology and Pharmaceutical Companies
o Academic and Research Institutes
o Others
• By Region
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East & Africa
GCC Countries
Israel
Rest of Middle East & Africa
• Key Players Insights
o Thermo Fisher Scientific, Inc.,
o Illumina Inc.
o ArcherDX, Inc.
o Roche Holding AG
o Pacific Biosciences
o CD Genomics, Atreca, Inc.
o Adaptive Biotechnologies
o Oxford Nanopore Technologies, Ltd.
o Qiagen N.V.
o Agilent Technologies, Inc.
o Takara Bio, Inc.
目錄 Table of Contents
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Product Type
Market Snippet, By Application
Market Snippet, By End User
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Regulatory Landscape
o Product Recall
o Epidemiology Analysis
o Technology Overview
o PEST Analysis
o Porter’s Five Forces model
4. Global Immune Repertoire Sequencing Market, By Product Type, 2026 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026 – 2033
Segment Trends
o Assay Kits
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o T-Cell Receptor (TCR) Kits
o B-Cell Receptor (BCR) Kits
o Instruments
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
5. Global Immune Repertoire Sequencing Market, By Application, 2026 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026 – 2033
Segment Trends
o Cancer Immunotherapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Biomarker Discovery
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Autoimmune Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Vaccine Development and Efficacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Transplant Rejection and Tolerance
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Infectious Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Other Applications
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
6. Global Immune Repertoire Sequencing Market, By End User, 2026 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026 – 2033
Segment Trends
o Diagnostic Labs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Biotechnology and Pharmaceutical Companies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Academic and Research Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
7. Global Immune Repertoire Sequencing Market, By Region, 2026 – 2033, (USD Mn)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, By Region, 2026 – 2033
Regional Trends
o North America
Market Size and Forecast, By Product Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2026 – 2033, (USD Mn)
Market Size and Forecast, By End User, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o U.S.
o Canada
o Europe
Market Size and Forecast, By Product Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2026 – 2033, (USD Mn)
Market Size and Forecast, By End User, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Size and Forecast, By Product Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2026 – 2033, (USD Mn)
Market Size and Forecast, By End User, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o China
o Japan
o India
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Latin America
Market Size and Forecast, By Product Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2026 – 2033, (USD Mn)
Market Size and Forecast, By End User, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Africa
Market Size and Forecast, By Product Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2026 – 2033, (USD Mn)
Market Size and Forecast, By End User, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o North Africa
o Central Africa
o South Africa
o Middle East
Market Size and Forecast, By Product Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2026 – 2033, (USD Mn)
Market Size and Forecast, By End User, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o GCC Countries
o Israel
o Rest of Middle East
8. Competitive Landscape
o Company Profiles
Thermo Fisher Scientific, Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Illumina Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
ArcherDX, Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Roche Holding AG
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Pacific Biosciences
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
CD Genomics
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Atreca, Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Adaptive Biotechnologies
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Oxford Nanopore Technologies, Ltd.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Qiagen N.V.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Agilent Technologies, Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Takara Bio, Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Analyst Views
9. Section
o References
o Research Methodology
o About Us and Sales Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們